Background: Differentiating tuberculous pleural effusion from other lymphocytic pleural effusions is often challenging. This retrospective study aimed to assess the efficacy and safety of medical thoracoscopy in patients with suspected tuberculous pleural effusion. Methods: Between July 2005 and June 2014, patients with pleural effusions of unknown etiologies underwent medical thoracoscopy in our institute after less invasive means of diagnosis had failed. Demographic, radiographic, procedural, and histological data of patients with tuberculous pleural effusion were analyzed. Results: During this 9-year study, 333 of 833 patients with pleural effusion were confirmed to have tuberculous pleurisy. Under thoracoscopy, we observed pleural nodules in 69.4%, pleural adhesion in 66.7%, hyperemia in 60.7%, plaque-like lesions in 6.0%, ulceration in 1.5% of patients with tuberculous pleurisy. Pleural biopsy revealed the presence of Mycobacterium tuberculosis in the pleural tissue or/and demonstration of caseating granulomas in 330 (99.1%) patients. No serious adverse events were recorded, and the most common minor complication was transient chest pain (43.2%) from the indwelling chest tube. Conclusions: Our data showed that medical thoracoscopy is a simple procedure with high diagnostic yield and excellent safety for the diagnosis of tuberculous pleural effusion.
Introduction
Tuberculosis accounts for millions of active disease cases and deaths in both developed and developing countries. Pulmonary infection with Mycobacterium tuberculosis is the most common form of tuberculosis, tuberculous pleural effusion (TPE) remains a frequent form of extrapulmonary tuberculosis [1, 2] . In addition, tuberculosis is the most common cause of exudative effusions in areas with a high prevalence of tuberculosis [2, 3] . TPE can develop from either a primary M. tuberculosis infection or disease reactivation [2, 4] . TPE is curable, therefore, making an accurate diagnosis as early as possible becomes essential. However, differentiating TPE from the many other causes of lymphocytic pleural effusions is often challenging. Diagnosis of TPE depends on the demonstration of M. tuberculosis in pleural fluid or pleura tissue, or demonstration of epithelioid cell granulomas and/or caseating granulomas in the pleura [1, 5] . Sensitivity of pleural fluid smear for acid-fast bacilli is very low (0e1%) [5e7], while mycobacterial culture of pleural fluid and/or pleural biopsy specimens is relatively sensitive (24e58%) [6e9], but is time consuming and requires standardized laboratories. Even with advanced culture techniques, the diagnostic yield is 63% for effusion culture [10] . Medical thoracoscopy (MT) refers to the examination of the pleural space in a nonintubated patient under local anesthesia, and this procedure has been well documented to be highly sensitive and safe for diagnosing exudative pleural effusions [11e13]. To our knowledge, this study is the first to evaluate usage and safety of MT in the diagnosis of TPE.
Methods

Study population
The study protocol was approved by the Institutional Review Boards for human studies of Beijing Chaoyang Hospital, China. The detailed medical history, clinical presentation, laboratory examination results, and image data of all patients with undiagnosed exudative pleural effusions who underwent MT in our institute between July 2005 and June 2014 were recorded, and only those data of patients with definite diagnosis of TPE were included in the current study. Before MT, all patients underwent the initial diagnostic workup, which includes measurement of a pleural fluid marker for tuberculosis, including adenosine deaminase, and their pleural effusions remain undiagnosed. The characteristics of the study population are presented in Table 1 .
All patients have had a thoracic computed tomography (CT) scan within 24 h before undergoing MT. According to the techniques described by Moy and colleagues, the size of a pleural effusion was estimated as small, moderate, or large according to CT imaging with anteroposterior quartile and maximum anteroposterior depth measured at the midclavicular line [14] : first anteroposteriorquartile effusions are small, second anteroposterior-quartile effusions are moderate, and third or fourth anteroposterior-quartile effusions are large.
Thoracoscopic procedures
MT was performed by chest physicians in our pulmonary procedural suite. After written informed consent was obtained, the patient was positioned with the affected side up in the lateral decubitus position. The patient breathed spontaneously with supplemental oxygen via nasal cannula as needed. The patient was connected to blood pressure, cardiac, and pulse oximetry monitors. Aloka ultrasound system (Aloka Co. Ltd, Tokyo, Japan) was used to confirm effusion presence and evaluate the best trocar entry site, generally located at the mid-to anterior axillary line, between the sixth to eighth intercostal space.
Under moderate sedation using fentanyl and midazolam, the skin, subcutaneous tissue, adjacent ribs, and parietal pleura were anesthetized with 1% lidocaine (15e30 mL), and a small incision was made at the planned site of entry. The 8-mm disposable trocar was then inserted, and a semi-rigid pleuroscope (Olympus LTF-240, Tokyo, Japan) was introduced into the pleural space right after all fluid was drained completely. A detailed inspection of the pleural cavity was then performed, with documentation of any abnormalities by photographic and/or video recordings. Biopsies were performed with flexible forceps under direct visual control in all suspect areas, systematically in several parts of the parietal pleura for mycobacterial, cytological, and histological examination. In addition, biopsy of the parietal pleura was performed over a rib to avoid the neurovascular bundle.
At the end of the procedure, a 24F chest drain was inserted for drainage. Chest radiographs were routinely obtained after the procedure and re-check until the removal of the chest tube.
Diagnostic criteria for TPE
The diagnosis of TPE was established by the presence of M. tuberculosis in biopsy specimen, or by demonstration of caseating granulomas or epithelioid cell granulomas in pleural tissue with no evidence of other granulomatous diseases.
Statistical analysis
Data are presented as mean ± standard deviation (SD) or number with percentage. Descriptive statistical methods were used for data analysis.
Results
Between July 2005 and June 2014, 833 patients with undiagnosed pleural effusions successfully underwent MT, and pleural biopsy samples were obtained for diagnostic evaluation. Eventually, TPE was the final diagnosis in 333 (40.0%) patients with lymphocytic exudates; the mean age of TPE patients was 51.8 ± 18.5 years.
As shown in Table 1 , the most common symptoms of TPE were cough (64.6%), breathlessness (60.7%), fever (48.1%), chest pain (35.7%), expectoration (32.4%), and weight loss (18.3%).
In 127 (38.1%) TPE patients, pleural fluid occurred only on the left side, in 161 (48.4%) only on the right, and in 45 (13.5%) both sides were affected (Table 2 ). In either unilateral or bilateral effusion, the percentages of small, moderate, and large size of pleural effusions were 20.4%, 19.2%, and 60.4%, respectively. Overall, in 15.3% of patients, the appearance of pleural effusion was bloodstained, in 84.4% was yellow, and in 0.3% was chylous. In addition to pleural effusion, CT imaging revealed pulmonary consolidation or infiltration (53.5%), pulmonary atelectasis (43.5%), mediastinal lymphopathy (41.1%), pleural thickening (33.3%), pulmonary mass or nodules (21.9%), and pleural nodularity 13 (3.9%) ( Table 2) .
Under MT, one or more abnormalities could be observed on the surface of parietal or/and visceral pleura in all patients studied. As shown in Fig. 1 and Table 3 , we observed pleural nodules in 231 (69.4%) patients, pleural adhesion in 222 (66.7%), hyperemia in 202 (60.7%), plaque-like lesions in 20 (6.0%), and ulcer in 5 (1.5%). Generally, the above pleural abnormalities due to TPE distributed diffusely on the surface of the involved pleura.
Eventually, MT biopsies yielded tuberculosis pathology in 330 (99.1%) patients by demonstration of one or more of following histological abnormalities in pleural biopsy specimen: 1) acid-fast bacillus; 2) caseating granulomas; 3) epithelioid cell granuloma with no evidence of other granuloma diseases (Fig. 2 and Table 4 ). We noted that the growth of M. tuberculosis in pleural fluid was negative in all patients, while positive culture results could be seen in pleural biopsy specimen from 3 patients with TPE.
In the 3 patients for whom pleural biopsies were inconclusive, a diagnosis of TPE was secured after isolation of M. tuberculosis in sputum cultured during the follow up period; pleural effusion resolution and clinical improvement was seen with antituberculous chemotherapy.
During this 9-year study, no serious adverse events were recorded in any one patient. As shown in Table 5 , among the minor adverse events were 144 (43.2%) patients of local pain requiring additional analgesic. 9.0% of patients had subcutaneous emphysema who recovered after chest-tube drainage. No major bleeding, and minor bleeding was seen in 7.5% of patients. 4.5% of patients had transient self-limited fever (38 C or more). 0.3% of patients had empyema caused by methicillin-sensitive Staphylococcus aureus who recovered after chest-tube drainage and antibiotic treatment.
Discussion
Differentiating diagnosis of TPE and the other exudative pleural effusions is always difficult, since sometimes they may have similar clinical manifestations and laboratory characteristics in the absence of pathological or etiological evidence. Since June 2005, MT has been being performed routinely in our institute for the patients with exudative pleural effusion not having any diagnosis by either clinical, radiologic, laboratory, or cytologic investigation. During this 9-year period, a total of 833 patients with undiagnosed pleural effusions underwent MT successfully, and 333 of them were eventually confirmed to suffer from TPE.
More than 90% of all pleural effusions in the developed countries are caused by congestive heart failure, malignancy, pneumonia, and pulmonary embolism, while tuberculosis is a common cause of pleural effusions in the developing countries [2, 15] . In 2011, there were 8.7 million new cases of active tuberculosis worldwide and 1.4 million deaths [3] . From 1990 to 2010, the prevalence of smear-positive tuberculosis decreased from 170 (95% Fig. 1 . Thoracoscopic images taken from patients with tuberculous pleurisy showing A) tuberculous nodules with irregular distribution on parietal pleura; B) tuberculous nodules on parietal (upper) and visceral (bottom) pleura; C) multiple military tuberculous nodules on parietal pleura; D) diffuse parietal pleura nodules and pleural adhesions; E) parietal pleural hyperemia with necrosis of the pleural node; F) parietal pleural hyperemia with white pleural plaques. confidence interval, 166e174) patients to 59 (49e72) patients per 100,000 Chinese population, however, China still had an estimated 1 million new tuberculosis cases in 2010, accounting for 11% of global tuberculosis incidence [16] . Moreover, 34.2% (30.9e37.6%) of the new cases of tuberculosis and 54.5% (49.6e59.4%) of the previously treated cases were resistant to at least one of the first-line anti-tuberculosis drugs; 5.7% (4.5e7.0%) of new cases and 25.6% (21.5e29.8%) of previously treated cases were multidrug-resistant tuberculosis [17] . As a matter of fact, tuberculosis continues to be one of the most common causes of mortality and morbidity due to infectious cause in China. Our recent unpublished data showed that during the past 3-year period, the cause of pleural effusions in 10.7% (165/1541) of patients admitted to our hospital was tuberculosis. TPE develops after rupture into the pleural space of a subpleural lung parenchymal caseous focus followed by a delayed hypersensitivity reaction to the mycobacterial protein. The mycobacterial load is often low and explains why microscopic examination of pleural fluid is rarely positive [5e7]. Culture of pleural fluid takes several weeks are required to grow M. tuberculosis with very low sensitivity (24e58%) [6e9]. Where diagnostic difficulty exists, a number of biomarkers in pleural fluid have been evaluated extensively for the diagnostic purpose of TPE, and our meta-analyses demonstrated that INF-g and adenosine deaminase are two valuable indicators for diagnosing TPE [18, 19] . More recently, we and the others have shown that IL-27 in pleural fluid is a sensitive and specific biomarker for the differential diagnosing TPE from pleural effusions with the other causes [20e22] . One key criticism of using these biomarkers rather than culture or biopsy examinations for the diagnosis of TPE is that none of the biomarkers provide definite etiologic diagnosis. It can only be accepted that a definite diagnosis In all patients studied, we found one or more abnormalities on the surface of parietal or/and visceral pleura, and these abnormalities included pleural nodules, pleural adhesion, hyperemia, pleural plaques, and ulcer. The most important finding of our current study was that almost all patients with TPE (99.1%) could be diagnosed by performing pleural biopsy under MT. Our data indicated that MT is a very efficacious diagnostic procedure for the management of TPE in China, a developing country with high tuberculosis prevalence.
It should be mentioned that CT-or ultrasound-guided pleural biopsies have been demonstrated to be helpful for the investigation of pleural effusions [23, 24] ; and it has been suggested the imageguided pleural needle biopsy can be used as the primary method of diagnosis in patients with pleural thickening identified by CT which can be targeted [23, 25, 26] . However, for those patients with only pleural fluid appearance on CT and in those who may have benign pleural pathologies, excluding conditions such as hepatic hydrothorax and congestive heart failure, the primary method of diagnosis should be MT [25] . As a matter of fact, neither blind needle biopsies nor image-assisted biopsies have being widespread for diagnosing TPE in most hospitals in China.
The fact that MT is a safe procedure in the diagnosis of exudative pleural effusions has been documented in the previous reviews [11, 12] . A recent meta-analysis also revealed that there was no mortality with the procedure, and that the rates of major and minor complications are 1.5% and 10.5%, respectively [13] . Our current data also showed that no serious adverse events were recorded in any one patient in this 9-year study, and that the most common minor complication was transient chest pain from the indwelling chest tube. Therefore, MT is a very safe procedure in the diagnosis of TPE.
One strengthen of the current study was that a large size of study population was investigated, in which 333 patients with TPE were included. On the other hand, our study also had limitations. First, this was not a prospective study, all required data were collected and analyzed retrospectively. Second, few patients in our series underwent blind needle biopsies or image-assisted biopsies before undergoing MT. This was an in part explanation why there were so many patients with pleural effusion (833 cases) undergoing MT in our institute during a period of 9 years.
In conclusion, MT is an efficacious procedure in the diagnosis of TPE. It is a simple method with high diagnostic yield and excellent safety. In the developing countries (i.e. China) with high tuberculosis prevalence, MT should be particularly helpful for the management of patients with clinically suspected TPE.
